Sunjeet Sawhney
Directeur Général chez Rappta Therapeutics Oy
Profil
Sunjeet Sawhney currently works at Rappta Therapeutics Oy, as Chief Executive Officer from 2021.
Mr. Sawhney received his graduate degree from the University of London.
Postes actifs de Sunjeet Sawhney
| Sociétés | Poste | Début |
|---|---|---|
Rappta Therapeutics Oy
 Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Directeur Général | 15/09/2021 |
Formation de Sunjeet Sawhney
| University of London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |